Zobrazeno 1 - 9
of 9
pro vyhledávání: '"C W, Serby"'
Autor:
C. Hill, L. Dunn, D. Auerbach, Sheldon R. Braun, M. Gilman, J. Rowlands, Mitchell Friedman, A. Gorin, C. W. Serby, R. Baughman, S. Weiss, J. Liu, Joe W. Ramsdell, R. Libert, A. Warmer, Michael C. Boyars, G. Mestas, G. Colice, S. C. Campbell, R. O'Connor, B. Levine, A. S. Buist, S. Jenkinson, T. Chick, B. M. Cohen, Nicholas J. Gross
Publikováno v:
Chest. 112:1514-1521
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b7e2007b101ba1192cf690865be616b
https://doi.org/10.1378/chest.112.6.1514
https://doi.org/10.1378/chest.112.6.1514
Autor:
A Wanner, S S Menjoge, Richard ZuWallack, T Witek, Richard Casaburi, C W Serby, Paul W. Jones, Pedro G San, D A Mahler
Publikováno v:
The European respiratory journal. 19(2)
Currently available inhaled bronchodilators used as therapy for chronic obstructive pulmonary disease (COPD) necessitate multiple daily dosing. The present study evaluates the long-term safety and efficacy of tiotropium, a new once-daily anticholiner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d216052eb6a1ea7222cfe0d46677d73a
https://pubmed.ncbi.nlm.nih.gov/11865999
https://pubmed.ncbi.nlm.nih.gov/11865999
Publikováno v:
Chest. 118(5)
To compare the bronchodilator efficacy and safety of tiotropium and placebo.A 3-month, randomized, double-blind, placebo-controlled, multicenter trial.Outpatient.Four hundred seventy patients with stable COPD (mean FEV(1) = 38.6% predicted).Tiotropiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6251927b55da8b1a090112c56b64ac9c
https://pubmed.ncbi.nlm.nih.gov/11083677
https://pubmed.ncbi.nlm.nih.gov/11083677
Publikováno v:
Chest. 110(1)
Bronchodilators are routinely used in the long-term therapy of patients with COPD. These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term and short-term benefits, however, are not necessarily equivalent. We evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f5bfba15c604c90bacbe74d875ad75e
https://pubmed.ncbi.nlm.nih.gov/8681663
https://pubmed.ncbi.nlm.nih.gov/8681663
Publikováno v:
Chest. 85(4)
The effectiveness of inhaled fenoterol doses of 0.4 mg and 0.8 mg in preventing exercise-induced asthma was investigated in 12 patients. Exercise-induced asthma was prevented by both doses for two hours after administration, but the effect of neither
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1852b9937096307335e6af88dd1a67ee
https://pubmed.ncbi.nlm.nih.gov/6368141
https://pubmed.ncbi.nlm.nih.gov/6368141
Publikováno v:
Clinical allergy. 11(6)
The effectiveness of inhaled versus oral metaproterenol in preventing exercise-induced asthma (EIA) was studied. Inhaled metaproterenol given 10 min before the exercise significantly reduced the degree of EIA in a group of twenty-four patients, and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7408556a71a932a992611ebbdcc5806c
https://pubmed.ncbi.nlm.nih.gov/7333003
https://pubmed.ncbi.nlm.nih.gov/7333003
Publikováno v:
Journal of Clinical & Diagnostic Research. Feb2015, Vol. 9 Issue 2, p10-13. 4p.
Publikováno v:
Clinical Allergy: Journal of the British Allergy Society. Nov1981, Vol. 11 Issue 6, p597-604. 8p. 4 Charts, 2 Graphs.
Publikováno v:
Clinical Allergy: Journal of the British Allergy Society. Jan1981, Vol. 11 Issue 1, preceding p1-1. 5p.